Dr Jack Wilson
Matilda Centre
Faculty of Medicine and Health
Jack Wilson is a Postdoctoral Research Fellow at the Matilda Centre for Research in Mental Health and Substance Use, within The University of Sydney. Jack's PhD investigated the long-term relationship between cannabis and opioid use. His current research focus is on the harms and benefits of cannabis use, as well as implications for Australian cannabis policy. Jack has held previous research roles at the National Drug and Alcohol Research Centre (NDARC) and the Addictions Department at King’s College, London.
Publications
Journals
- Oliver, D., Murray, R., Freeman, T., Fusar-Poli, P., McGuire, P., Englund, A., Chesney, E., Chester, L., Wilson, J., Sovi, S., et al (2024). Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study. Addiction, 119(2), 322-333. [More Information]
- Chester, L., Englund, A., Chesney, E., Oliver, D., Wilson, J., Sovi, S., Dickens, A., Oresic, M., Linderman, T., Hodsoll, J., et al (2024). Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study. Cannabis and Cannabinoid Research, 9(1), 188-198. [More Information]
- Santo, T., Degenhardt, L., Gisev, N., Campbell, G., Colledge, S., Wilson, J., Tran, L., Lynch, M., Martino-Burke, D., Taylor, S. (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. International Journal of Drug Policy, 128, 104434. [More Information]
2024
- Oliver, D., Murray, R., Freeman, T., Fusar-Poli, P., McGuire, P., Englund, A., Chesney, E., Chester, L., Wilson, J., Sovi, S., et al (2024). Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study. Addiction, 119(2), 322-333. [More Information]
- Chester, L., Englund, A., Chesney, E., Oliver, D., Wilson, J., Sovi, S., Dickens, A., Oresic, M., Linderman, T., Hodsoll, J., et al (2024). Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study. Cannabis and Cannabinoid Research, 9(1), 188-198. [More Information]
- Santo, T., Degenhardt, L., Gisev, N., Campbell, G., Colledge, S., Wilson, J., Tran, L., Lynch, M., Martino-Burke, D., Taylor, S. (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. International Journal of Drug Policy, 128, 104434. [More Information]
2023
- Wilson, J., Mills, K., Sunderland, M., Freeman, T., Teesson, M., Haber, P., Marel, C. (2023). Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence. International Journal of Mental Health and Addiction. [More Information]
- Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., et al (2023). Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology, 48(6), 869-876. [More Information]
- Marel, C., Madden, E., Wilson, J., Teesson, M., Mills, K. (2023). Effectiveness of online training for improving knowledge, attitudes, and confidence of alcohol and other drug workers in relation to co-occurring mental health conditions. Drugs: education, prevention and policy, 30(2), 115-123. [More Information]
2022
- Visontay, R., Sunderland, M., Slade, T., Wilson, J., Mewton, L. (2022). Are there non-linear relationships between alcohol consumption and long-term health?: a systematic review of observational studies employing approaches to improve causal inference. BMC Medical Research Methodology, 22(1), 16. [More Information]
- Santo, T., Campbell, G., Gisev, N., Martino-Burke, D., Wilson, J., Colledge-Frisby, S., Clark, B., Tran, L., Degenhardt, L. (2022). Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence, 238. [More Information]
- Wilson, J., Mills, K., Freeman, T., Sunderland, M., Visontay, R., Marel, C. (2022). Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction, 117(2), 284-298. [More Information]
2021
- Mackie, C., Wilson, J., Freeman, T., Craft, S., Escamilla De La Torre, T., Lynskey, M. (2021). A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity. Addictive Behaviors, 117, 1-8. [More Information]
- Visontay, R., Sunderland, M., Slade, T., Wilson, J., Mewton, L. (2021). Are there non-linear relationships between alcohol consumption and long-term health? Protocol for a systematic review of observational studies employing approaches to improve causal inference. BMJ Open, 11(3), e043985-1-e043985-8. [More Information]
- Freeman, T., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., Lynskey, M. (2021). Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction, 116(5), 1000-1010. [More Information]
2020
- Chesney, E., Oliver, D., Green, A., Sovi, S., Wilson, J., Englund, A., Freeman, T., McGuire, P. (2020). Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology, 45(11), 1799-1806. [More Information]
- Marel, C., Mills, K., Visontay, R., Wilson, J., Darke, S., Ross, J., Slade, T., Haber, P., Haasnoot, K., Keaveny, M., Teesson, M., et al (2020). Australian treatment outcome study: Protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use. BMJ Open, 10(7), e039226. [More Information]
- Chester, L., Chesney, E., Oliver, D., Wilson, J., Englund, A. (2020). How experimental cannabinoid studies will inform the standardized THC unit. Addiction, 115(7), 1217-1218. [More Information]
2019
- Wilson, J., Freeman, T., Mackie, C. (2019). Effects of increasing cannabis potency on adolescent health. The Lancet Child and Adolescent Health, 3(2), 121-128. [More Information]
2018
- Freeman, T., Wilson, J., Mackie, C. (2018). Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perception. Addiction, 113(6), 1086-1087. [More Information]
In the media
https://au.rollingstone.com/culture/culture-features/interview-with-a-cannabis-expert-45723/
https://shows.acast.com/addiction-audio/episodes/cannabis-opioids-and-the-gateway-hypothesis-with-jack-wilson
https://www.bbc.co.uk/programmes/m0007zly